课题基金 / 基金详情

Trained immunity in the retina and its influence on retinal degenerative disorders

Trained immunity in the retina and its influence on retinal degenerative disorders
视网膜的训练免疫力及其对视网膜退行性疾病的影响
批准号:
459037870
负责人:
Professor Dr. Thomas Langmann
金额:
$0.0万
依托单位:
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
--
资助国家:
德国
项目状态:
未结题
起止时间:

项目摘要

项目成果

Professor Dr. Thomas Langmann的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We and others have shown that when retinal microglia become pathologically activated by sustained stimulation, they release inflammatory mediators which are detrimental to vision-producing retinal neurons. However, it is not yet clear which molecular mechanisms underpin these exaggerated responses. Our preliminary data in the laser model of choroidal neovascularization indicates the presence of innate immune memory in the retina. Therefore, the goal of this study is to further investigate the role of trained immunity in the development of maladaptive inflammatory responses in the mouse retina with the aim of better understanding the immunological basis of retinal degenerative disorders. The proposed study is subdivided into two specific aims. In specific aim 1, we will endeavor to determine whether immunological memory can be imprinted in the retina by in vivo exposure to a metabolic or microbial microglial priming stimulus (peripheral or local application) to generate an enhanced inflammatory response to subsequent genetically or experimentally induced retinal damage. We will apply in vivo imaging, microglia histomorphometry and three different high throughput sequencing methods (RNA-seq, ATAC-Seq, ChIP-seq) in two different mouse models that mimic some important neuropathological features of human retinitis pigmentosa and atrophic age-related macular degeneration and determine how immune memory in the retina can modify disease pathogenesis. In specific aim 2, we will perform a proof-of concept study and determine whether blocking immunological memory in retinal microglia using cell-specific knockout of transforming growth factor-activated kinase 1 (Tak1), a key epigenetic pathway for immune training, can positively influence disease outcome in the two mouse models of retinal pathology. Successful completion of this work will uncover mechanisms governing immune cell activation in the retina and explore the potential interactions between long-term exposure to environmental and lifestyle stressors that may contribute to the development and progression of retinal pathologies. Importantly, completing the proposed work holds promise to identify critical mediators of trained immunity in the retina and pave the way towards new strategies for mitigating retinal pathologies with an inflammatory component.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of complement receptors and microglia in age-related macular degeneration
  • 批准号:
    268718306
  • 项目类别:
    Research Units
  • 资助金额:
    $0.0万
  • 财政年份:
    2015
  • 负责人:
    Professor Dr. Thomas Langmann
  • 依托单位:
Funktionelle Analyse des FAM161A Proteins und Aufklärung der FAM161A-assoziierten Netzhautdegeneration
  • 批准号:
    202925333
  • 项目类别:
    Research Units
  • 资助金额:
    $0.0万
  • 财政年份:
    2011
  • 负责人:
    Professor Dr. Thomas Langmann
  • 依托单位:
Mikroglia bei Netzhautdegeneration
  • 批准号:
    82941880
  • 项目类别:
    Research Units
  • 资助金额:
    $0.0万
  • 财政年份:
    2008
  • 负责人:
    Professor Dr. Thomas Langmann
  • 依托单位:
Molekulare Charakterisierung der Mikroglia-Aktivierung bei der Netzhautdegeneration
  • 批准号:
    39154083
  • 项目类别:
    Research Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    2007
  • 负责人:
    Professor Dr. Thomas Langmann
  • 依托单位:
国内基金
海外基金
SENP5调控磷酸化STAT2的SUMO修饰促进抗病毒天然免疫的机制研 究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    胡源
  • 依托单位:
外周犬尿氨酸通过脑膜免疫致海马BDNF水平降低介导术后认知功能障碍
  • 批准号:
    82371193
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    苏殿三
  • 依托单位:
microRNA对机体抗病毒固有免疫应答RIG-I信号途径的调控作用及机制研究
C型凝集素样受体识别在原发性皮肤毛霉病中的作用
  • 批准号:
    81171510
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2011
  • 负责人:
    李若瑜
  • 依托单位: